Ember Therapeutics Broadens Brown Fat Small Molecule Drug Discovery Portfolio, Secures Exclusive License Options to Intellectual Property for Three Small Molecule Targets
10/4/2012 10:10:55 AM
More...
|
Ember Therapeutics Announces Cell Publication of Key Data Showing TRPV4 Inhibition Activates Brown/Beige Fat and Protects Against Obesity, Inflammation and Insulin Resistance
9/27/2012 10:26:57 AM
More...
|
Ember Therapeutics Expands Scientific Leadership to Advance Metabolic Pipeline
5/30/2012 9:56:52 AM
More...
|
Pure Communications Release: Ember Therapeutics Secures Exclusive License to Key Brown Fat Technology and Intellectual Property from the Joslin Diabetes Center
3/28/2012 6:52:41 AM
More...
|
Ember Therapeutics Launched with $34 Million to Focus on Metabolic Disorders
12/15/2011 6:37:33 AM
More...
|